One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-137025
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
Affiliation: Stony Brook University, Pitié-Salpêtrière Hospital, Sorbonne Université, Institut Jules Bordet, Hôpital Lyon Sud, Northwestern Medical Faculty Foundation, Oxford University Hospitals NHS Trust, Tel Aviv University, Rabin Medical Center, Hospital Universitario Virgen del Rocío, Karyopharm Therapeutics (United States), University of Chicago, King's College Hospital, NewYork–Presbyterian Hospital, Presbyterian Hospital, New York Hospital Queens, Cornell University, University of Turin, Medical University of Vienna, Cancer Research UK, University of Southampton, NIHR CRUK Experimental Cancer Medicine Centre, University of Liverpool, Cleveland Clinic, University Hospitals of Cleveland, Leiden University Medical Center, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Hôpital Saint-Louis, Délégation Paris 7, Assistance Publique – Hôpitaux de Paris, Hackensack University Medical Center, Inserm, Institute Paoli-Calmettes, Addenbrooke's Hospital, Cliniques Universitaires Saint-Luc, The University of Texas MD Anderson Cancer Center, Ghent University Hospital
Selinexor Efficacy and Safety Are Independent of Renal Function in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis from the Pivotal Phase 2b Sadal Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
